Tuberculosis protein EccB5 triggers deadly cell death and bacterial spread

Tuberculosis is still a leading global health threat, in part because the bacterium Mycobacterium tuberculosis (Mtb) causes intense cell damage that helps it spread and wreck tissues. Researchers have long known that a form of inflammatory cell death called pyroptosis — driven by the host protein GSDMD — can make tuberculosis worse, but how the bacterium triggers this process was unclear. In new work led by Jixi Li, scientists set out to find the bacterial factor responsible for pushing infected immune cells into destructive pyroptosis. Focusing on Mtb’s secretion systems, they homed in on a component called EccB5 from the ESX-5 secretion machinery. Rather than studying broad responses alone, the team dissected how this single effector influenced infected macrophages, bacterial dissemination, and lung pathology. Their aim was to move beyond correlation and reveal a specific molecular interaction that explains how Mtb turns a host defense mechanism into an advantage for infection. By tracing effects from molecules to whole tissues, the study connects a bacterial protein to cellular death and to worse disease in infected lungs.

The research identifies EccB5, a component of the Mtb ESX-5 secretion system, as a key driver of pyroptosis and hyperinflammatory responses. Experimentally, the presence of EccB5 increased Mtb virulence by inducing pyroptosis of macrophages, which in turn promoted bacterial dissemination and exacerbated lung pathology. When the researchers used conditional knockdown EccB5, host cell viability improved, demonstrating that lowering EccB5 levels blunted the cytotoxic effect. At the molecular level, the team found that EccB5 directly interacts with GSDMD, the pore-forming protein central to pyroptosis. EccB5 strengthened GSDMD’s association with caspase-1 and facilitated caspase-1-mediated cleavage of GSDMD both in vitro and in vivo. These linked observations show a chain of events from an identifiable Mtb effector through host protease activity to the activation of a cell-death effector, tying the bacterial protein to measurable outcomes in cells and in infected tissue.

The study uncovers a precise mechanism by which Mtb modulates host responses and advances its pathogenicity. By showing that EccB5 connects directly to GSDMD and helps caspase-1 cut GSDMD into its active form, the work explains how the bacterium co-opts pyroptosis to promote its own spread and to worsen lung damage. This clarity matters because it points to a specific bacterial factor — EccB5 — that is central to a harmful host-pathogen interaction, rather than to a vague set of inflammatory signals. For researchers and clinicians, understanding this molecular link offers a clearer target for future studies aimed at preventing excessive tissue damage and limiting dissemination: interventions that disrupt the EccB5–GSDMD–caspase-1 axis could, in principle, reduce the destructive pyroptosis that contributes to severe tuberculosis. At the same time, the findings emphasize how a single bacterial effector can reshape host biology to the pathogen’s advantage, highlighting the value of detailed molecular investigation in infectious disease research.